Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCY4F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,512
Award facts
- Contract value 100% obligated
- $13,512.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,512.30 to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Wegovy 1.7 mg/0.75 mL pens. This is a firm fixed-price delivery order with an ultimate completion date of January 8, 2026, and no set-aside designation, meaning it was awarded through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031.
AmerisourceBergen is a major pharmaceutical distributor providing critical medical supply chain support to federal healthcare systems, including the Defense Health Agency, U.S. Coast Guard, and other government medical institutions. The Wegovy supply supports military and federal healthcare programs' diabetes and weight management treatment needs. As a primary vendor under the DLA Troop Support Medical IDC, AmerisourceBergen regularly fulfills delivery orders for a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains serving military treatment facilities and veterans' healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FCY4F?
SPE2DR26FCY4F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FCY4F worth?
The government has obligated $13,512 on SPE2DR26FCY4F.
Is contract SPE2DR26FCY4F an order under another contract?
Yes. SPE2DR26FCY4F is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCY4F competed?
The extent of competition for SPE2DR26FCY4F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award